Felicity Kalinowski

Home  >  Felicity Kalinowski

Research Officer

Felicity Kalinowski

Translational Cancer Research Project and
Perkins Cancer Biobank

Felicity Kalinowski completed her Undergraduate degree at the University of Western Australia in 2008. She completed and was awarded First Class Honours at UWA/Perkins in 2009. Felicity commenced as a Research Assistant at the Perkins in 2010. She joined the Translational Cancer Research Program in 2020 where she currently works on nucleic acid extraction, and sample preparation for Whole Exome Sequencing and RNAseq for the Liver Cancer Collaborative and Perkins Cancer Biobank.

Research Officer

Felicity Kalinowski

Translational Cancer Research Project and
Perkins Cancer Biobank

Contact details

+61 8 6151 0764

[email protected]

Publications

Barker A, Giles KM, Epis MR, Zhang PM, Kalinowski F, Leedman PJ. 2010, ‘Regulation of ErbB receptor signalling in cancer cells by microRNA’, Curr. Opin. Pharmacol. 10:6 655-661. https://doi.org/10.1016/j.coph.2010.08.011

Horsham JL, Ganda C, Kalinowski FC, Brown RAM, Epis MR, Leedman PJ. 2015, ‘MicroRNA-7: A miRNA with expanding roles in development and disease, Int. J. Biochem. Cell Biol. 69 215-224. https://doi.org/10.1016/j.biocel.2015.11.001

Horsham JL, Kalinowski FC, Epis MR, Ganda C, Brown RAM, Leedman PJ. 2015,’Clinical Potential of microRNA-7 in Cancer’. J. Clin. Med. 4, 1668-1687. https://doi.org/10.3390/jcm4091668

Kalinowski FC, Brown RA, Ganda C, Giles KM, Epis MR, Horsham J, Leedman PJ. 2014. ‘microRNA-7: a tumor suppressor miRNA with therapeutic potential’. Int J Biochem Cell Biol. 54:312-7. https://doi.org/10.1016/j.biocel.2014.05.040

Giles KM, Kalinowski FC, Candy PA, Epis MR, Zhang PM, Redfern AD, Stuart LM, Goodall GJ, Leedman PJ. ‘Axl mediates acquired resistance of head and neck cancer cells to the epidermal growth factor receptor inhibitor erlotinib’. 2013. Mol Cancer Ther. 12(11):2541-58. https://doi.org/10.1158/1535-7163.MCT-13-0170

Giles KM, Brown RA, Epis MR, Kalinowski FC, Leedman PJ. 2012. ‘miRNA-7-5p inhibits melanoma cell migration and invasion’. Biochem Biophys Res Commun. 430(2):706-10. https://doi.org/10.1016/j.bbrc.2012.11.086

Kalinowski FC, Giles KM, Candy PA, Ali A, Ganda C, Epis MR, Webster RJ, Leedman PJ. 2012. ‘Regulation of epidermal growth factor receptor signaling and erlotinib sensitivity in head and neck cancer cells by miR-7’. PLoS One. 7(10):e47067. https://doi.org/10.1371/journal.pone.0047067

Epis MR, Giles KM, Kalinowski FC, Barker A, Cohen RJ, Leedman PJ. 2012. ‘Regulation of expression of deoxyhypusine hydroxylase (DOHH), the enzyme that catalyzes the activation of eIF5A, by miR-331-3p and miR-642-5p in prostate cancer cells’. J Biol Chem., 287(42):35251-35259. https://doi.org/10.1074/jbc.m112.374686

Barker A, Giles KM, Epis MR, Zhang PM, Kalinowski F, Leedman PJ. 2010. ‘Regulation of ErbB receptor signalling in cancer cells by microRNA’. Curr Opin Pharmacol. 10(6):655-61. https://doi.org/10.1016/j.coph.2010.08.011

Close Menu